The National Pharmaceutical Pricing Authority has approved the price hike of ceiling prices of eight scheduled drugs.

Researchers are investigating whether diabetes and eye disease drugs could also be used to treat or even prevent dementia.

In another Gazzette notification, the drug pricing regulator fixed the retail price of 20 new drugs under the provisions of ...

SpyGlass Pharma released 18-month follow-up data highlighting the potential of its (IOL)-based drug delivery platform.

Explore the open-angle glaucoma drugs market, highlighting innovative treatments, key players, and emerging trends in managing this chronic condition. The open-angle glaucoma drugs market is ...

My daughter phoned last week to get my opinion about her friend’s dog. She was upset because the little dog had developed ...

India’s drug pricing agency has raised by 50 per cent the price caps on 11 formulations of eight drugs used to treat asthma, glaucoma and tuberculosis among other health disorders, the Centre ...

Ceiling prices were also revised for the asthma drug Salbutamol in tablets of 2 mg and 4 mg formulations and respirator ...

Glaucoma Therapeutics MarketThe global glaucoma therapeutics market is projected to be valued at approximately USD 6.9 ...

Most of these drugs are low cost and generally used as first-line treatment crucial to the public health programmes of the ...

New Delhi: India’s apex drug pricing regulator Monday allowed a 50 percent rise in the prices of 8 essential drugs used by ...

Spinogenix is using small molecule drugs to regenerate synapses in patients with ALS, Alzheimer's disease, schizophrenia, ...